CATHERINE BLUME: Open Payments
NPI 1083602056 · PLATTEVILLE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 40 payments from 16 companies in 2025. Trend: 2023 $1,284 · 2024 $921 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| PFIZER INC. | 2 | $48 |
| Dexcom, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 4 | $35 |
| Inspire Medical Systems, Inc. | 2 | $33 |
Products named: VRAYLAR, CAPLYTA, JARDIANCE, GEMTESA, ZORYVE, NURTEC ODT, Dexcom G6 Transmitter, VOQUEZNA.
Industry payments across WI — which companies pay providers there.
